乌鲁木齐市维吾尔族急性缺血性脑梗塞合并非酒精性脂肪性肝病患者的临床分析

陈芹芹; 梁灿灿; 杨丽君; 孟清; 丁永年

doi:10.3969/j.issn.1001-5256.2018.06.025

乌鲁木齐市维吾尔族急性缺血性脑梗塞合并非酒精性脂肪性肝病患者的临床分析

DOI: 10.3969/j.issn.1001-5256.2018.06.025

新疆医科大学第二附属医院消化科

基金项目:

新疆医科大学科技创新基金项目(XJC201361)；

详细信息

中图分类号: R575.5;R743.3
计量
- 文章访问数: 1927
- HTML全文浏览量: 43
- PDF下载量: 338
- 被引次数: 0
出版历程
- 收稿日期: 2017-11-30
- 出版日期: 2018-06-20

A clinical analysis of Uygur patients with acute ischemic cerebral infarction complicated by nonalcoholic fatty liver disease in Urumqi, China

Department of Gastroenterology, The Second Affiliated Hospital of Xinjiang Medical University

Research funding:

摘要

摘要:
目的探讨乌鲁木齐市维吾尔族急性缺血性脑梗塞（AICI）患者合并非酒精性脂肪性肝病（NAFLD）的临床特点及可能的危险因素。方法回顾性分析新疆医科大学第二附属医院2011年9月-2017年7月收治的294例维吾尔族AICI患者的临床资料,根据腹部超声诊断分为病例组（合并NAFLD者）110例和对照组（非合并NAFLD者）184例。观察2组患者的基本情况,生化指标及颈总动脉内膜中层厚度（IMT）。另将所收集病例根据年龄分为5组（≤30岁组、3145岁组、4660岁组、6175岁组和≥76岁组）,比较各年龄组AICI患者NAFLD发生情况。计量资料组间比较采用t检验。计数资料2组间比较采用χ2检验。多因素分析采用logistic多元回归分析。结果病例组患者年龄、BMI、腰臀比、糖化血红蛋白、空腹血糖、尿酸、ALT、GGT、TG、TC、LDL-C等指标显著高于对照组,AST水平显著低于对照组,2组间差异均有统计学意义（t值分别为9.814、5.569、8.139、3.592、3.514、15.703、15.113、8.092、1...
- 非酒精性脂肪性肝病 /
- 脑梗死 /
- 维吾尔族
Abstract:
Objective To investigate the association between acute ischemic cerebral infarction (AICI) and nonalcoholic fatty liver disease (NAFLD) in Uygur patients in Urumqi, China and possible risk factors. Methods A retrospective analysis was performed for the clinical data of 294 Uygur patients with AICI who were admitted to The Second Affiliated Hospital of Xinjiang Medical University from September2011 to July 2017, and according to the diagnosis based on abdominal ultrasound, these patients were divided into case group with 110 patients (AICI complicated by NAFLD) and control group with 184 patients (without NAFLD) . The two groups were observed in terms of general information, biochemical parameters, and intima-media thickness (IMT) of the common carotid artery. The AICI patients were divided into ≤30 years group, 31-45 years group, 46-60 years group, 61-75 years group, and ≥60 years group according to age, and the incidence rate of NAFLD was compared between these groups. The t-test was used for comparison of continuous data between groups, the chi-square test was used for comparison of categorical data between groups, and a multivariate logistic regression analysis was performed.Results Compared with the control group, the case group had significantly higher age, body mass index, waist-hip ratio, Hb A1 c, fasting blood glucose, uric acid, alanine aminotransferase (ALT) , gamma-glutamyl transpeptidase, triglyceride (TG) , total cholesterol, and low-density lipoprotein cholesterol (LDL-C) and a significantly lower aspartate aminotransferase level (t = 9. 814, 5. 569, 8. 139, 3. 592, 3. 514, 15. 703, 15. 113, 8. 092, 10. 834, 7. 719, 11. 481, and 7. 561, all P < 0. 05) . The case group had a significantly higher proportion of the patients with a smoking history than the control group (χ2= 14. 060, P < 0. 05) . The logistic regression analysis showed that the increases in age (odds ratio [OR]= 1. 301, 95% confidence interval [CI]: 1. 065-1. 589, P < 0. 05) and serum levels of ALT (OR =1. 383, 95% CI: 1. 059-1. 805, P < 0. 05) , TG (OR = 1. 335, 95% CI: 1. 091-1. 634, P < 0. 05) , and LDL-C (OR = 1. 358, 95%CI: 1. 125-1. 639, P < 0. 05) and a smoking history (OR = 1. 423, 95% CI: 1. 105-1. 833, P < 0. 05) were closely associated with NAFLD in AICI patients. The incidence rate of NAFLD in AICI patients increased with age, and there was a significant difference between different age groups (χ2= 13. 558, P = 0. 009) ; the 61-75 years group and the > 76 years group had an incidence rate of NAFLD of44. 09% and 51. 35%, respectively, which were significantly higher than that in the other three groups (P < 0. 05) . Conclusion Increases in age and serum levels of ALT, TG, and LDL-C and a smoking history are independent risk factors for NAFLD in patients with AICI, and AICI patients aged over 60 years have a high incidence rate of NAFLD.
- nonalcoholic fatty liver disease /
- brain infarction /
- uygur nationality

HTML全文

参考文献(16)

[1]FENG G, NIU CY.Advances in the treatment of nonalcoholic fatty liver disease[J].J Clin Hepatol, 2017, 33 (12) :2433-2438. (in Chinese) 冯巩, 牛春燕.非酒精性脂肪性肝病的洽疗进展[J].临床肝胆病杂志, 2017, 33 (12) :2433-2438.

[2]BRENT A, NEUSCHWANDER T.Non-alcoholic fatty liver disease[J].BMC Med, 2017, 15 (1) :45.

[3]XUE L, MENG CR, LIU JW.Epidemiological survey of prevalence of nonalcoholic fatty liver disease in examination receivers of Urumqi[J].J Xinjiang Med Univ, 2009, 32 (9) :1346-1349. (in Chinese) 薛黎, 孟存仁, 刘继文.乌鲁木齐市健康体检人群非酒精性脂肪性肝病患病状况调查[J].新疆医科大学学报, 2009, 32 (9) :1346-1349.

[4]HONG HC, HWANG SY, RYU JY, et al.The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis[J].Clin Endocrinol (Oxf) , 2015, 84 (2) :203-209.

[5]THAN NN, NEWSOME PN.Non-alcoholic fatty liver disease:when to intervene and with what[J].Clin Med, 2015, 15 (2) :186-190.

[6]CHEN MM, ZHANG SY, CHEN GY, et al.Risk of acute ischemic stroke in patients with non-alcoholic fatty liver diseases[J].J Pract Hepatol, 2015, 18 (2) :150-155. (in Chinese) 陈梅梅, 张舒宜, 陈光榆, 等.非酒精性脂肪性肝病与急性脑梗塞相关性临床分析[J].实用肝脏病杂志, 2015, 18 (2) :150-155.

[7] Neurology Branch of Chinese Medical Association.Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2014[J].Chin J Neurol, 2015, 48 (4) :246-257. (in Chinese) 中华医学会神经病学分会.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志, 2015, 48 (4) :246-257.

[8] Group of Fatty Liver and Alcoholic Liver Diseases, Society of Hepatology, Chinese medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].实用肝脏病杂志, 2010, 26 (2) :120-124.

[9]BROTT T, ADAMS HP, OLINGER CP, et al.Measurements of acute cerebral infarction:A clinical examination scale[J].Stroke, 1989, 20 (7) :864-870.

[10]GHOSH M, GHOSH K, CHATTERJEE A, et al.Correlation of intracranial atherosclerosis with carotid stenosis in ischemic stroke patients[J].Ann Indian Acad Neurol, 2015, 18 (4) :412-414.

[11]TARGHER G, BERTOLINI L, PADOVANI R, et al.Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes[J].J Hepatol, 2010, 53 (4) :713-718.

[12]MUSSO G, GAMBINO R, CASSADER M, et al.Meta-analysis:natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity[J].Ann Med, 2011, 43 (8) :617-649.

[13]BAO T, CAI SH, ZHANG ZM, et al.Clinical features of cerebral infarction in patients with nonalcoholic fatty liver disease[J].Clin Focus (Med J) , 2013, 28 (5) :540-542. (in Chinese) 包婷, 柴守华, 张征民, 等.非酒精性脂肪肝脑梗死患者的临床特征[J].临床荟萃, 2013, 28 (5) :540-542.

[14]ZHANG XL.Feasibility of alanine aminotransferase/aspartate aminotransferase ratio in predicting hepatic steatosis in chronic hepatitis C patients[J].J Clin Hepatol, 2017, 33 (6) :1096-1100. (in Chinese) 张秀丽.ALT与AST比值预测慢性丙型肝炎患者肝脂肪变性的可行性分析[J].临床肝胆病杂志, 2017, 33 (6) :1096-1100.

[15]FAN JG, FARREL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol, 2009, 50 (1) :204-210.

[16]LIU HX, LIU Y, LENG S.Correlation between and non-alcoholic fatty liver disease and metabolic syndrome[J].Chin J Diabetes, 2011, 19 (7) :535-538. (in Chinese) 刘海霞, 刘颖, 冷松.非酒精性脂肪性肝病与代谢综合征的相关性研究[J].中国糖尿病杂志, 2011, 19 (7) :535-538.

施引文献

资源附件(0)

访问统计